Skip to main content

Table 1 Demographic and medical details of the study participants

From: Associations between indicators of lipid and glucose metabolism and hypothyroidism

Characteristic

Overall

Hypothyroidism

P value

Yes

No

Unweighted number

3254

280

2974

 

Weighted number

279,259,824

25,306,247

253,953,577

 

Gender

   

< 0.0011

 Male

47.49%

24.89%

49.74%

 

Age

44 ± 16

52 ± 18

43 ± 15

< 0.0012

Race

   

< 0.0011

 Mexican American

8.81%

3.94%

9.29%

 

 Non-Hispanic White

67.61%

84.35%

65.95%

 

 Non-Hispanic Black

11.41%

5.26%

12.03%

 

 Other Race

12.16%

6.44%

12.73%

 

Educational level

   

0.2431

 Below high school

18.31%

14.53%

18.69%

 

 High school degree or comparable

21.83%

20.04%

22.00%

 

 Some college or associate’s degree

29.70%

28.04%

29.86%

 

 Beyond college

30.17%

37.40%

29.45%

 

Marital Status

   

0.6161

 Married

53.74%

55.55%

53.56%

 

PIR

2.73 (1.55, 4.83)

2.92 (1.62, 5.00)

2.73 (1.55, 4.80)

0.3123

BMI (kg/m2)

27.10 (23.72, 31.51)

27.81 (24.15, 32.30)

27.07 (23.70, 31.44)

0.1233

Hypertension

   

0.0041

 

28.12%

41.52%

26.79%

 

Diabetes mellitus

   

0.0141

 

7.68%

12.39%

7.22%

 

Cardiovascular disease

   

0.0171

 

4.08%

7.80%

3.71%

 

Alcohol consumption

   

0.1681

 

79.35%

75.24%

79.76%

 

Smoking status

   

0.0791

 

43.57%

38.35%

44.08%

 

FPG (mg/dL)

99 (92, 106)

98 (92, 106)

99 (92, 106)

0.4433

FT3 (pg/mL)

3.20 (3.00, 3.50)

3.01 (2.80, 3.30)

3.22 (3.00, 3.50)

< 0.0013

FT4 (pmol/L)

0.80 (0.70, 0.90)

0.80 (0.70, 0.90)

0.80 (0.70, 0.89)

0.0353

TSH (mIU/L)

1.65 (1.13, 2.44)

4.62 (2.12, 5.68)

1.58 (1.12, 2.27)

< 0.0013

TGAb (IU/mL)

0.60 (0.60, 0.60)

0.60 (0.60, 4.30)

0.60 (0.60, 0.60)

< 0.0013

TPOAb (IU/mL)

0.70 (0.30, 1.80)

2.79 (0.60, 72.62)

0.60 (0.30, 1.50)

< 0.0013

TG (mg/dL)

104 (74, 148)

121 (88, 160)

103 (73, 147)

< 0.0013

TC (mg/dL)

194 (171, 222)

200 (178, 227)

194 (170, 221)

0.0153

LDL-C (mg/dL)

117 (96, 140)

119 (99, 141)

117 (96, 140)

0.2473

HDL-C (mg/dL)

52 (43, 63)

56 (45, 67)

52 (43, 62)

0.0333

non-HDL-C (mg/dL)

141 (116, 167)

148 (123, 173)

140 (116, 166)

0.0413

RC (mg/dL)

21 (15, 30)

24 (18, 32)

21 (15, 29)

< 0.0013

LDL/HDL-C

2.25 (1.67, 2.95)

2.20 (1.75, 3.02)

2.26 (1.67, 2.95)

0.7973

TG/HDL-C

1.99 (1.24, 3.30)

2.12 (1.37, 3.50)

1.98 (1.22, 3.28)

0.1373

NHHR

2.72 (1.97, 3.60)

2.65 (2.01, 3.90)

2.73 (1.96, 3.59)

0.8733

TC/HDL-C

3.72 (2.97, 4.60)

3.65 (3.01, 4.90)

3.73 (2.96, 4.59)

0.8733

RC/HDL-C

0.40 (0.25, 0.66)

0.43 (0.27, 0.70)

0.40 (0.25, 0.66)

0.1423

METS-IR

39.76 (33.00, 47.74)

41.24 (33.04, 49.82)

39.67 (33.00, 47.49)

0.3253

TyG

8.56 ± 0.58

8.70 ± 0.54

8.55 ± 0.59

< 0.0012

AIP

0.30 ± 0.30

0.34 ± 0.30

0.30 ± 0.30

0.0972

  1. Continuous variables: normal distribution was expressed as mean ± standard deviation and non-normal distribution was expressed as median (interquartile range). Categorical variables were presented in percentages
  2. PIR ratio of household income to poverty, BMI body mass index, FPG fasting plasma glucose, FT3 free triiodothyronine, FT4 free thyroxine, TSH thyroid stimulating hormone, TGAb thyroglobulin antibodies, TPOAb thyroid peroxidase antibodies, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, RC remnant cholesterol, NHHR non-HDL-C to HDL-C ratio, METS-IR metabolic score for insulin resistance, TyG triglyceride-glucose index, AIP atherogenic index of plasma, OR odds ratio, CI confidence interval